Announcements - Search results

Search results: Company announcements for
ANTISENSE THERAPEUTICS LIMITED (ANP)
Released between 01/01/2017 and 31/12/2017

Didn't find the announcement you were after? Search again.

Announcements released as ANP
Date Price sens. Headline
22/12/2017
9:58 AM
asterix ATL1103/atesidorsen Early Access Program Agreement
3 pages 50.4KB
19/12/2017
9:51 AM
asterix ATL1102 for MS and DMD Update
2 pages 51.1KB
29/11/2017
5:40 PM
  Results of Meeting
2 pages 716.3KB
29/11/2017
12:11 PM
  AGM Presentation
16 pages 816.7KB
21/11/2017
9:58 AM
asterix ATL1102 for MS and DMD Update
1 page 24.8KB
09/11/2017
9:03 AM
  Receipt of R&D Tax Incentive payment
1 page 17.5KB
31/10/2017
8:51 AM
asterix Appendix 4C - quarterly
5 pages 794.3KB
30/10/2017
9:01 AM
  ATL1102 Black Hole MS Data Presented at Gobal Conference
2 pages 236.0KB
27/10/2017
2:52 PM
  Notice of Annual General Meeting/Proxy Form/Annual Report
81 pages 3.3MB
17/10/2017
9:32 AM
asterix ATL1102 for MS and DMD Update
2 pages 137.3KB
02/10/2017
9:34 AM
asterix ATL1102 for MS and DMD Update
2 pages 30.0KB
28/09/2017
4:07 PM
  Annual Report
64 pages 2.8MB
28/09/2017
4:07 PM
  Appendix 4G
13 pages 140.4KB
12/09/2017
9:24 AM
asterix ATL1102 for MS and DMD Update
2 pages 29.9KB
30/08/2017
9:02 AM
asterix ATL1102 Black Hole MS data to be presented at MS Conference
1 page 23.2KB
29/08/2017
5:58 PM
asterix Full Year Statutory Accounts
71 pages 1.0MB
31/07/2017
8:51 AM
asterix Appendix 4C - quarterly
5 pages 101.6KB
27/07/2017
9:38 AM
asterix ATL1102 for Multiple Sclerosis Phase IIb trial Update
1 page 23.4KB
26/06/2017
10:11 AM
asterix Antisense Therapeutics to enter clincial development in DMD
19 pages 1.8MB
26/06/2017
10:00 AM
asterix ATL1102 for MS Phase IIb IND submitted to the FDA
1 page 44.7KB
16/06/2017
9:08 AM
asterix Positive effects with ATL1102 on MS Black Hole lesions
2 pages 46.5KB
18/05/2017
9:06 AM
asterix ATL1103 Update
2 pages 46.4KB
27/04/2017
9:15 AM
asterix Appendix 4C - quarterly
5 pages 100.7KB
24/04/2017
8:59 AM
asterix ATL1102 for MS Phase IIb Investigational New Drug Submission
1 page 31.5KB
24/03/2017
9:21 AM
asterix Market and Technology Update
2 pages 364.8KB
01/03/2017
8:44 AM
  Change of Director's Interest Notice (RM)
2 pages 22.8KB
24/02/2017
8:23 AM
asterix ATL1103 Patent Update
2 pages 30.4KB
24/02/2017
8:11 AM
asterix Half Year Accounts
25 pages 372.7KB
23/02/2017
9:15 AM
  Proposed International Nonproprietary Name for ATL1103
2 pages 25.2KB
16/02/2017
9:42 AM
asterix ATL1102 for MS - Progress Update
2 pages 31.6KB
13/02/2017
9:21 AM
  Change of Director's Interest Notice (RM, MD)
4 pages 39.2KB
08/02/2017
10:31 AM
  Completion of Less Than Marketable Parcel Share Sale Program
1 page 25.1KB
30/01/2017
9:15 AM
asterix Appendix 4C - quarterly
5 pages 93.5KB
19/01/2017
8:57 AM
  Final Trading Day for ANPO Listed Options
1 page 63.2KB
16/01/2017
11:58 AM
  Expiry of ANPO Listing Options
1 page 66.4KB
09/01/2017
12:00 PM
  Change of Director's Interest Notice (RM)
2 pages 41.7KB
04/01/2017
8:59 AM
  Corporate Presentation
15 pages 1.5MB

Useful Information

Other companies that have used the code 'ANP'

  • AUSTRALIAN PETROLEUM FUND - previously known as
  • BA PETROLEUM EXPLORERS TRUST

view available announcements for this company

Didn't find the announcement you were after? Search again.

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.